Different morphological structures of breast tumors demonstrate individual drug resistance gene expression profiles
Aim: To identify gene expression profiles involved in drug resistance of different morphological structures (tubular, alveolar, solid, trabecular, and discrete) presented in breast cancer. Material and Methods: Ten patients with luminal breast cancer have been included. A laser microdissection-assis...
Saved in:
| Published in: | Experimental Oncology |
|---|---|
| Date: | 2018 |
| Main Authors: | Gerashchenko, T.S., Denisov, E.V., Novikov, N.M., Tashireva, L.A., Kaigorodova, E.V., Savelieva, O.E., Zavyalova, M.V., Cherdyntseva, N.V., Perelmuter, V.M. |
| Format: | Article |
| Language: | English |
| Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2018
|
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/145587 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Different morphological structures of breast tumors demonstrate individual drug resistance gene expression profiles / T.S. Gerashchenko, E.V. Denisov, N.M. Novikov, L.A. Tashireva, E.V. Kaigorodova, O.E. Savelieva, M.V. Zavyalova, N.V. Cherdyntseva, V.M. Perelmuter // Experimental Oncology. — 2018 — Т. 40, № 2. — С. 228–234. — Бібліогр.: 37 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
The phenomenon of multi-drug resistance in the treatment of malignant tumors
by: Vtorushin, S.V., et al.
Published: (2014)
by: Vtorushin, S.V., et al.
Published: (2014)
Heterogeneity of premetastatic niches gene expression in breast cancer cells
by: L. A. Tashireva, et al.
Published: (2015)
by: L. A. Tashireva, et al.
Published: (2015)
The phenomenon of multi-drug resistance in the treatment of malignant tumors
by: S. V. Vtorushin, et al.
Published: (2014)
by: S. V. Vtorushin, et al.
Published: (2014)
Clinicopathological features of nonspecific invasive breast cancer according to its molecular subtypes
by: Zavyalova, M., et al.
Published: (2016)
by: Zavyalova, M., et al.
Published: (2016)
Circulating tumor cells in breast cancer: functional heterogeneity, pathogenetic and clinical aspects
by: Cherdyntseva, N.V., et al.
Published: (2017)
by: Cherdyntseva, N.V., et al.
Published: (2017)
The peculiarities of gene expression of medullary breast carcinoma tumor-associated antigensin different types of breast tumors
by: M. A. Shyian, et al.
Published: (2012)
by: M. A. Shyian, et al.
Published: (2012)
The scientific-practical conference "Individualization of drug treatment of patients with solid tumors"
by: N. I. Fedosova
Published: (2018)
by: N. I. Fedosova
Published: (2018)
The peculiarities of gene expression of medullary breast carcinoma tumor-associated antigens in different types of breast tumors
by: Shyian, А., et al.
Published: (2012)
by: Shyian, А., et al.
Published: (2012)
Generalized optimization of drug transport in tumors
by: D. A. Kliushyn, et al.
Published: (2020)
by: D. A. Kliushyn, et al.
Published: (2020)
Mice with pituitary tumor transforming gene ( pttg ) knockout demonstrate increased urinary space in renal corpuscles
by: Yu. Varyvoda, et al.
Published: (2014)
by: Yu. Varyvoda, et al.
Published: (2014)
Mice with pituitary tumor transforming gene (pttg) knockout demonstrate increased urinary space in renal corpuscles
by: Varyvoda, O.Yu., et al.
Published: (2014)
by: Varyvoda, O.Yu., et al.
Published: (2014)
Research of stem tumor cells subpopulation on models of breast cancer
by: T. S. Herheliuk, et al.
Published: (2022)
by: T. S. Herheliuk, et al.
Published: (2022)
Allogeneic screening of tumor associated antigens of human breast cancer
by: O. I. Kostianets, et al.
Published: (2012)
by: O. I. Kostianets, et al.
Published: (2012)
The redox-state indices of breast adipose tissue is important factor of tumor microenvironment in patients with breast cancer
by: A. P. Burlaka, et al.
Published: (2019)
by: A. P. Burlaka, et al.
Published: (2019)
Activity and functional characteristics of cytochrome P450 in tumors and breast adipose tissue of patients with breast cancer
by: A. P. Burlaka, et al.
Published: (2019)
by: A. P. Burlaka, et al.
Published: (2019)
Ultrastructural changes in tumor cells treated with liposomal forms of anticancer drugs
by: Yurchenko, O.V., et al.
Published: (2010)
by: Yurchenko, O.V., et al.
Published: (2010)
Clinical and immunohistochemical features of primary breast cancer and metachronous ovarian and endometrial tumors
by: Kryzhanivska, A.E., et al.
Published: (2018)
by: Kryzhanivska, A.E., et al.
Published: (2018)
Dynamics of the Demonstration Formal Rules in the Healthcare Sphere
by: V. V. Serzhanov, et al.
Published: (2022)
by: V. V. Serzhanov, et al.
Published: (2022)
Expression of CD40 by the cells of benign and malignant breast tumors and antitumor action of autologous lymphocytes against chemoresistant and chemosensitive tumors
by: Bereznaya, N.M., et al.
Published: (2008)
by: Bereznaya, N.M., et al.
Published: (2008)
Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
by: Lukianova, N.Yu., et al.
Published: (2023)
by: Lukianova, N.Yu., et al.
Published: (2023)
Quantifying uncertainty of a mathematical model of drug transport in tumors
by: S. Essarrout, et al.
Published: (2022)
by: S. Essarrout, et al.
Published: (2022)
Features of architectonics of neoplasms and molecular profile of tumor cells in patients with breast cancer
by: L. A. Nalieskina, et al.
Published: (2018)
by: L. A. Nalieskina, et al.
Published: (2018)
EpCAM expression in breast tumor cells and their relation to clinical and pathological parameters and molecular subtype of cancer
by: L. M. Kovalevska, et al.
Published: (2019)
by: L. M. Kovalevska, et al.
Published: (2019)
Individualization of neoadjuvant therapy in patients with locally-distributed breast cancer
by: Ju. Ju. Belevtsova
Published: (2019)
by: Ju. Ju. Belevtsova
Published: (2019)
Expression of ITSN2 and TKS5 in different subtypes of breast cancer tumors
by: Kropyvko, S.V., et al.
Published: (2019)
by: Kropyvko, S.V., et al.
Published: (2019)
Cytogenetic effects of neutron therapy in patients with parotid gland tumors and relapse of breast cancer
by: Melnikov, A.A., et al.
Published: (2012)
by: Melnikov, A.A., et al.
Published: (2012)
Aspisol inhibits tumor growth and induces apoptosis in breast cancer
by: Zhu, X.G., et al.
Published: (2008)
by: Zhu, X.G., et al.
Published: (2008)
Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
by: Yalovenko, T.M., et al.
Published: (2016)
by: Yalovenko, T.M., et al.
Published: (2016)
A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
by: O. V. Shepil, et al.
Published: (2014)
by: O. V. Shepil, et al.
Published: (2014)
A study of transferrin and ferritin expression in tumor cells of patients with breast cancer
by: Shepil, O.V., et al.
Published: (2014)
by: Shepil, O.V., et al.
Published: (2014)
DEMONSTRATIVE BASIS OF THE PARADIGM BANGING OF THE EARTH
by: MURAVEINYK, Yu.A.
Published: (2013)
by: MURAVEINYK, Yu.A.
Published: (2013)
Concerning the demonstration of one theorem of Grunbaum
by: Petrenyuk, A. Ya., et al.
Published: (1971)
by: Petrenyuk, A. Ya., et al.
Published: (1971)
Integral characteristic of the immune system state predicts breast cancer outcome
by: Stakheyeva, M., et al.
Published: (2023)
by: Stakheyeva, M., et al.
Published: (2023)
Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
by: S. M. Hrybach, et al.
Published: (2018)
by: S. M. Hrybach, et al.
Published: (2018)
Lactoferrin expression in breast cancer in relation to biologic properties of tumors and clinical features of disease
by: Naleskina, L.A., et al.
Published: (2016)
by: Naleskina, L.A., et al.
Published: (2016)
Receptor status of tumor as prognostic factor in patients with bilateral breast cancer
by: D. Y. Tsyhyka, et al.
Published: (2013)
by: D. Y. Tsyhyka, et al.
Published: (2013)
Receptor status of tumor as prognostic factor in patients with bilateral breast cancer
by: Tsyhyka, D.Y., et al.
Published: (2013)
by: Tsyhyka, D.Y., et al.
Published: (2013)
Analysis of the survival of patients with breast cancer depending on age, molecular subtype of tumor and metabolic syndrome
by: Grybach, S.M., et al.
Published: (2018)
by: Grybach, S.M., et al.
Published: (2018)
The Clinical Significance of Tumor MIR-122, -155, -182, and -200b Expression in Patients with Breast Cancer
by: V. F. Chekhun, et al.
Published: (2017)
by: V. F. Chekhun, et al.
Published: (2017)
Smart nanocarriers for drug delivery: controllable LSPR tuning
by: Lopatynskyi, A.M., et al.
Published: (2016)
by: Lopatynskyi, A.M., et al.
Published: (2016)
Similar Items
-
The phenomenon of multi-drug resistance in the treatment of malignant tumors
by: Vtorushin, S.V., et al.
Published: (2014) -
Heterogeneity of premetastatic niches gene expression in breast cancer cells
by: L. A. Tashireva, et al.
Published: (2015) -
The phenomenon of multi-drug resistance in the treatment of malignant tumors
by: S. V. Vtorushin, et al.
Published: (2014) -
Clinicopathological features of nonspecific invasive breast cancer according to its molecular subtypes
by: Zavyalova, M., et al.
Published: (2016) -
Circulating tumor cells in breast cancer: functional heterogeneity, pathogenetic and clinical aspects
by: Cherdyntseva, N.V., et al.
Published: (2017)